Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 24597251)

1.

Effect of short-term tibolone treatment on risk markers for cardiovascular disease in healthy postmenopausal women: a randomized controlled study.

Traianos A, Vavilis D, Makedos A, Karkanaki A, Ravanos K, Prapas N, Tarlatzis BC.

Clin Exp Obstet Gynecol. 2013;40(4):542-5.

PMID:
24597251
2.

Effect of tibolone on markers of cardiovascular disease risk in postmenopausal women undergoing hemodialysis: a pilot study.

Ostberg JE, Damjanovic T, Dimkovic N, Byrne D, Mikhailidis DP, Prelevic GM.

Fertil Steril. 2004 Jun;81(6):1624-31.

PMID:
15193486
3.
4.

Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.

Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC.

Gynecol Endocrinol. 2004 May;18(5):244-57.

PMID:
15346660
6.

Short-term effect of tibolone on C-reactive protein in hypertensive postmenopausal women.

Engin-Ustün Y, Ustün Y, Türkçüoğlu I, Mutlu Meydanli M, Kafkasli A, Yetkin G.

Arch Gynecol Obstet. 2009 Mar;279(3):305-9. doi: 10.1007/s00404-008-0712-6. Epub 2008 Jun 27.

PMID:
18584186
7.

Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study.

Koh KK, Ahn JY, Jin DK, Yoon BK, Kim HS, Kim DS, Kang WC, Han SH, Choi IS, Shin EK.

Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1889-94. Epub 2003 Aug 21.

8.

A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women.

Prelevic GM, Kwong P, Byrne DJ, Jagroop IA, Ginsburg J, Mikhailidis DP.

Fertil Steril. 2002 May;77(5):945-51.

PMID:
12009348
9.

Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.

Castelo-Branco C, Vicente JJ, Figueras F, Sanjuan A, Martínez de Osaba MJ, Casals E, Pons F, Balasch J, Vanrell JA.

Maturitas. 2000 Feb 15;34(2):161-8.

PMID:
10714911
10.

Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B.

Castelo-Branco C, Casals E, Figueras F, Sanjuan A, Vicente JJ, Balasch J, Vanrell JA.

Menopause. 1999 Summer;6(2):92-7.

PMID:
10374214
11.
12.

[Effects of tibolone on the risk factors for cardiovascular diseases in postmenopausal women].

Jeremić K, Lazović G, Tulić I, Gojnić M, Stojnić J, Jeremić J.

Vojnosanit Pregl. 2006 Apr;63(4):387-91. Serbian.

PMID:
16683408
13.

A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.

Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.

Climacteric. 2002 Mar;5(1):60-9. Erratum in: Climacteric 2002 Jun;5(2):vi.

PMID:
11974560
15.

Effects of oral estradiol and levonorgestrel on cardiovascular risk markers in postmenopausal women.

Terauchi M, Honjo H, Mizunuma H, Aso T.

Arch Gynecol Obstet. 2012 Jun;285(6):1647-56. doi: 10.1007/s00404-012-2222-9. Epub 2012 Jan 19.

PMID:
22258305
16.

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.

Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H.

Gynecol Endocrinol. 2005 May;20(5):258-63.

PMID:
16019370
17.

The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-alpha and hepatocyte growth factor in postmenopausal women.

Sezer Ozer K, Erenus M, Yoldemir T.

Climacteric. 2009 Feb;12(1):66-71. doi: 10.1080/13697130802479580.

PMID:
19012050
18.

Is serum ferritin an additional cardiovascular risk factor for all postmenopausal women?

Masse PG, Dosy J, Cole DE, Evroski J, Allard J, D'Astous M.

Ann Nutr Metab. 2004 Nov-Dec;48(6):381-9. Epub 2004 Nov 26.

PMID:
15583466
19.
20.

Effects of soy bean on serum paraoxonase 1 activity and lipoproteins in hyperlipidemic postmenopausal women.

Shidfar F, Ehramphosh E, Heydari I, Haghighi L, Hosseini S, Shidfar S.

Int J Food Sci Nutr. 2009 May;60(3):195-205. doi: 10.1080/09637480701669463. Epub 2008 May 15.

PMID:
18608549
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk